欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Chinese Journal of Natural Medicines CHIN J NAT MEDICINES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
63人评分
我要评分
声誉 7.5 影响力 5.3 速度 7.1 | |||||||||||||||||||||||||||||||
期刊ISSN | 2095-6975 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||||||||||||
E-ISSN | 1875-5364 | |||||||||||||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 4.9 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:4.922 | |||||||||||||||||||||||||||||||
2024-2025自引率 | 6.10%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.8 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.24 | |||||||||||||||||||||||||||||||
h-index | 27 | |||||||||||||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | https://www.sciencedirect.com/journal/chinese-journal-of-natural-medicines | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://mc03.manuscriptcentral.com/cjnm | |||||||||||||||||||||||||||||||
作者指南网址 | https://www.elsevier.com/journals/chinese-journal-of-natural-medicines/1875-5364/guide-for-authors | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Chinese Journal of Natural Medicines的语言要求,还能让Chinese Journal of Natural Medicines编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Chinese Journal of Natural Medicines编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | CHINESE JOURNAL NATURAL MEDICINES, 24, TONGJIA XIANG, NANJING, PEOPLES R CHINA, 210009 | |||||||||||||||||||||||||||||||
出版商 | China Pharmaceutical University | |||||||||||||||||||||||||||||||
涉及的研究方向 | INTEGRATIVE & COMPLEMENTARY MEDICINE-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||||||||
出版国家或地区 | PEOPLES R CHINA | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Bi-monthly | |||||||||||||||||||||||||||||||
出版年份 | 2003 | |||||||||||||||||||||||||||||||
年文章数 | 95点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 0.00% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 87.37% | |||||||||||||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-6975%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Chinese Journal of Natural Medicines顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇) 。 提交文稿 | |||||||||||||||||||||||||||||||
编辑信息 |
Editor-in-Chief Ling-Yi Kong China Pharmaceutical University, Nanjing, China Associate Editors-in-Chief Rudolf Bauer Karl Franzens University Graz Pharmacognosy, Graz, Austria Geoffrey A. Cordell Evanston, United States of America De-An Guo Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China Chun-fu Wu Shenyang Pharmaceutical University, Department of Pharmacology, Shenyang, China Bao-Quan Zhu China State Institute of Pharmaceutical Industry, Shanghai, China | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Evaluation of pharmacokinetics and metabolism of three marine-derived piericidins for guiding drug lead selection Author: Liang, Weimin; Lu, Jindi; Yu, Ping; Cai, Meiqun; Xie, Danni; Chen, Xini; Zhang, Xi; Tian, Lingmin; Yan, Liyan; Lan, Wenxun; Liu, Zhongqiu; Zhou, Xuefeng; Tang, Lan Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 614-629. DOI: 10.1016/S1875-5364(25)60866-1 PubMed DOI |
2. | A CYP80B enzyme from Stephania tetrandra enables the 3'-hydroxylation of N-methylcoclaurine and coclaurine in the biosynthesis of benzylisoquinoline alkaloids Author: Li, Yaoting; Feng, Yuhan; Guo, Wan; Gao, Yu; Zhang, Jiatao; Yang, Lu; Lei, Chun; Kang, Yun; Wang, Yaqin; Qu, Xudong; Huang, Jianming Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 630-640. DOI: 10.1016/S1875-5364(25)60867-3 PubMed DOI |
3. | Pristimerin induces Noxa-dependent apoptosis by activating the FoxO3a pathway in esophageal squamous cell carcinoma Author: Feng, Mengyuan; Zhang, Anjie; Wu, Jingyi; Cheng, Xinran; Yang, Qingyu; Gong, Yunlai; Hu, Xiaohui; Ji, Wentao; Yu, Xianjun; Zhao, Qun Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 585-592. DOI: 10.1016/S1875-5364(25)60865-X PubMed DOI |
4. | Advances in nanocarriers for targeted drug delivery and controlled drug release Author: Wang, Yuqian; Huang, Renqi; Feng, Shufan; Mo, Ran Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 513-528. DOI: 10.1016/S1875-5364(25)60861-2 PubMed DOI |
5. | Research advances in the treatment of arthritis from natural products (2014-present) Author: Wang, Ruilin; Ji, Cen; Chen, Jiayao; Zhang, Xiaohan; Hu, Qinghua; Liu, Chunxiao Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 529-540. DOI: 10.1016/S1875-5364(25)60862-4 PubMed DOI |
6. | Progress on the functions and mechanisms of natural products in anti-glioma therapy Author: Li, Yanting; Qu, Shuhui; Zuo, Jiayi; Long, Haoping; Cao, Feng; Jiang, Feng Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 541-559. DOI: 10.1016/S1875-5364(25)60815-6 PubMed DOI |
7. | Salidroside inhibits osteoclast differentiation based on osteoblast-osteoclast interaction via HIF-1α pathway Author: Jin, Yutong; Wang, Yao; Wang, Chuan; Zhang, Lingling; Gao, Dandan; Liu, Haizhao; Cao, Qingwen; Tian, Chenchen; Bian, Yuhong; Wang, Yue Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 572-584. DOI: 10.1016/S1875-5364(25)60864-8 PubMed DOI |
8. | Anti-cancer and anti-inflammatory effects of flavan-4-ol and flavan glycosides from the roots of Pronephrium penangianum Author: Huang, Feibing; Yang, Yong; Xie, Qingling; Yuan, Hanwen; Aamer, Muhammad; Jian, Yuqing; Zhang, Ye; Wang, Wei Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 593-603. DOI: 10.1016/S1875-5364(25)60814-4 PubMed DOI |
9. | Lingguizhugan Decoction improves chronic heart failure by synergistic-ally modulating β1-AR/Gs/GRKs/β-arrestin signaling bias Author: Guo, Shuting; Xia, Lei; Yang, Songru; Liang, Yueyang; Shan, Xiaoli; Zhao, Pei; Guo, Wei; Zhang, Chen; Xu, Ming; Sun, Ning; Lu, Rong; Chen, Huihua Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 560-571. DOI: 10.1016/S1875-5364(25)60863-6 PubMed DOI |
10. | Comprehensive analysis of the antibacterial activity of 5,8-dihydroxy-1,4-naphthoquinone derivatives against methicillin-resistant Staphylococcus aureus Author: Chen, Qingqing; Ding, Yuhang; Li, Zhongyi; Chen, Xingyu; Fazal, Aliya; Zhang, Yahan; Ma, Yudi; Wang, Changyi; Yang, Liu; Yin, Tongming; Lu, Guihua; Lin, Hongyan; Wen, Zhongling; Qi, Jinliang; Han, Hongwei; Yang, Yonghua Journal: CHINESE JOURNAL OF NATURAL MEDICINES. 2025; Vol. 23, Issue 5, pp. 604-613. DOI: 10.1016/S1875-5364(25)60818-1 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室